Ottawa, Canada

Toya Nath Baral

This inventor holds 1 USPTO granted patent, plus 3 CIPO patents and 1 EPO patent. Top assignee: National Research Council of Canada. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toya Nath Baral. Retrieved from https://idiyas.com/inventor/toya-nath-baral

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toya Nath Baral: Innovator in Antibody Therapeutics

Introduction

Toya Nath Baral is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions that have the potential to impact medical diagnostics and treatment.

Latest Patents

Toya Nath Baral holds a patent for "Anti-CEACAM6 antibodies and uses thereof." This invention relates to isolated or purified antibodies or fragments that are specific for CEACAM6. The patent outlines their use as therapeutic or diagnostic tools, specifically targeting a linear epitope of CEACAM6. The invention includes both in vivo and in vitro methods for diagnosis, as well as therapeutic applications.

Career Highlights

Baral is affiliated with the National Research Council of Canada, where she continues to advance her research in antibody therapeutics. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology.

Collaborations

Throughout her career, Toya Nath Baral has collaborated with notable colleagues, including Jianbing Zhang and Yanal Murad. These collaborations have further enriched her research and contributed to the advancement of her projects.

Conclusion

Toya Nath Baral is a distinguished inventor whose work in antibody therapeutics holds promise for future medical applications. Her innovative approach and dedication to research continue to make a significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…